Skip to main content
OpenTrials
Completed

NCT Number: NCT02981537

Two-staged Approach in Positioning Endobronchial Blockers Without Fiberoptic Guidance

The purpose of this study is to find a novel method for placing endobronchial blockers without fiberoptic guidance to provide one-lung isolation during anesthesia for thoracic surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Seoul National University Hospital

Seoul, 110-744, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients scheduled for lung resection

Exclusion criteria

  • refuse to enroll
  • patients with lesions involving mainstem bronchi
  • patients with anomalies in tracheobronchial tree

Treatment and study plan

two-staged endobronchial blocker insertion

Device

positioning endobronchial blockers in two-staged method

single-staged endobronchial blocker insertion

Device

positioning endobronchial blockers in traditional single-staged method

Primary outcomes

  1. location of endobronchial blocker

    Time frame: immediately after the insertion of blocker by fiberoptic bronchoscope

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Dec 5, 2016
Registry last updated
Jul 13, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.